Drug company tax windfalls are a chance to help Donald Trump keep his pledge to reduce prescription prices. But so far shareholders are getting the money.
from USATODAY - Opinion https://ift.tt/2JCjE19
via IFTTT
Drug companies get tax windfall, but they're not reducing prescription prices
from USATODAY - Opinion https://ift.tt/2JCjE19
via IFTTT
